Santos da Silva Jorge
Insider CIK 1920509 · MLTX Chief Executive Officer, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| MLTX MoonLake Immunotherapeutic | S Sale | 2026-07-10 | 2026-07-13 | 68,289 | $20.02 | $1.37M | 2,774,893 | SEC↗ |
| MLTX MoonLake Immunotherapeutic | S Sale | 2026-07-09 | 2026-07-13 | 33,936 | $20.01 | $679.1K | 2,843,182 | SEC↗ |
| MLTX MoonLake Immunotherapeutic | S Sale | 2026-07-01 | 2026-07-02 | 47,775 | $20.03 | $956.9K | 2,877,118 | SEC↗ |
| MLTX MoonLake Immunotherapeutic | S Sale | 2026-04-13 | 2026-04-14 | 51,873 | $18.23 | $945.6K | 2,924,893 | SEC↗ |
| MLTX MoonLake Immunotherapeutic | S Sale | 2026-04-10 | 2026-04-14 | 98,127 | $18.41 | $1.81M | 2,976,766 | SEC↗ |
| MLTX MoonLake Immunotherapeutic | A Award deriv | 2026-01-07 | 2026-01-09 | 520,342 | — | $0 | 520,342 | SEC↗ |
| MLTX MoonLake Immunotherapeutic | C Conversion deriv | 2025-12-19 | 2025-12-22 | 5,836 | — | $0 | 0 | SEC↗ |
| MLTX MoonLake Immunotherapeutic | C Conversion | 2025-12-19 | 2025-12-22 | 196,316 | — | $0 | 3,074,893 | SEC↗ |
| MLTX MoonLake Immunotherapeutic | D To issuer | 2025-12-19 | 2025-12-22 | 196,316 | — | $0 | 0 | SEC↗ |
| MLTX MoonLake Immunotherapeutic | S Sale | 2025-12-09 | 2025-12-10 | 70,000 | $14.49 | $1.01M | 2,878,577 | SEC↗ |
| MLTX MoonLake Immunotherapeutic | S Sale | 2025-12-08 | 2025-12-10 | 130,000 | $15.08 | $1.96M | 2,948,577 | SEC↗ |
| MLTX MoonLake Immunotherapeutic | A Award | 2025-02-27 | 2025-03-03 | 95,763 | — | $0 | 3,078,577 | SEC↗ |
| MLTX MoonLake Immunotherapeutic | S Sale | 2024-02-29 | 2024-02-29 | 4,740 | $55.89 | $264.9K | 2,982,814 | SEC↗ |
| MLTX MoonLake Immunotherapeutic | S Sale | 2024-02-28 | 2024-02-29 | 56,065 | $55.00 | $3.08M | 2,987,554 | SEC↗ |
| MLTX MoonLake Immunotherapeutic | S Sale | 2024-02-27 | 2024-02-29 | 62,810 | $55.00 | $3.45M | 3,043,619 | SEC↗ |
| MLTX MoonLake Immunotherapeutic | S Sale | 2024-02-21 | 2024-02-23 | 1,125 | $55.27 | $62.2K | 3,106,429 | SEC↗ |
| MLTX MoonLake Immunotherapeutic | S Sale | 2024-02-20 | 2024-02-20 | 20,000 | $57.44 | $1.15M | 3,107,554 | SEC↗ |
| MLTX MoonLake Immunotherapeutic | S Sale | 2024-02-16 | 2024-02-20 | 20,000 | $60.15 | $1.20M | 3,127,554 | SEC↗ |
| MLTX MoonLake Immunotherapeutic | S Sale | 2024-02-15 | 2024-02-20 | 20,000 | $60.18 | $1.20M | 3,147,554 | SEC↗ |
| MLTX MoonLake Immunotherapeutic | C Conversion deriv | 2023-10-01 | 2023-10-03 | 4,164 | — | $0 | 5,836 | SEC↗ |
| MLTX MoonLake Immunotherapeutic | C Conversion deriv | 2023-10-01 | 2023-10-03 | 90,000 | — | $0 | 0 | SEC↗ |
| MLTX MoonLake Immunotherapeutic | D To issuer | 2023-10-01 | 2023-10-03 | 140,071 | — | $0 | 217,374 | SEC↗ |
| MLTX MoonLake Immunotherapeutic | C Conversion | 2023-10-01 | 2023-10-03 | 3,027,483 | — | $0 | 3,027,483 | SEC↗ |
| MLTX MoonLake Immunotherapeutic | D To issuer | 2023-10-01 | 2023-10-03 | 3,027,483 | — | $0 | 0 | SEC↗ |
| MLTX MoonLake Immunotherapeutic | C Conversion | 2023-10-01 | 2023-10-03 | 140,071 | — | $0 | 3,167,554 | SEC↗ |